Latest Flecainide Stories
Digoxin, a drug that has been used worldwide for centuries to treat heart disease, is associated with a significant increase in deaths in patients with atrial fibrillation (AF).
Atrial fibrillation (AF) is the most frequently sustained arrhythmia of the heart.
UC Davis researchers have developed an accurate computer model to test the effects of medications for arrhythmia, or abnormal heart rhythm, before they are used in patients.
A Norwegian survey carried out between 1974 and 2003 showed that there was a graded independent increase in the risk of AF with increasing levels of physical activity in a population-based study among men with ostensibly no other heart disease.
New research has found that the answer to treating a rare inherited heart disorder could lie with a drug already on the market. Associate Professor Derek Laver from the University of Newcastle and international colleagues have found that Flecainide